cost–effectiveness of aumolertinib as first-line treatment for EGFR-mutated advanced nonsmall-cell lung cancer
Article in Future Oncology (September 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Future Oncology (September 2024)
Article in Cancer Medicine (August 2024)
Article in BMJ Open (August 2024)